Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps

December 6, 2012 7:29 AM EST Send to a Friend
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trading Halts

Add Your Comment